Reformable intramolecular cross-linking of the N-terminal domain of heparin cofactor II: Effects on enzyme inhibition

European Journal of Biochemistry

Volumn 271, Issue 21, 2004, Pages 4275-4283

  Brinkmeyer, Stephan ^a   Eckert, Ralf ^a   Ragg, Hermann ^a  

^a BIELEFELD UNIVERSITY   (Germany)

Author keywords

Thrombin; Dermatan sulfate; Heparin; Heparin cofactor II; Serpin(s)

Indexed keywords

CHYMOTRYPSIN A; DERMATAN SULFATE; DISULFIDE; DITHIOTHREITOL; GLYCOSAMINOGLYCAN; HEPARIN COFACTOR II; IODOACETAMIDE; PROTEINASE; SERINE PROTEINASE INHIBITOR; THROMBIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CROSS LINKING; CRYSTAL STRUCTURE; ENZYME INHIBITION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CHO CELLS; CHYMOTRYPSIN; COS CELLS; CRICETINAE; CROSS-LINKING REAGENTS; CYANOGEN BROMIDE; CYSTEINE; DERMATAN SULFATE; DISULFIDES; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; GLYCOSAMINOGLYCANS; HEPARIN; HEPARIN COFACTOR II; HUMANS; KINETICS; MODELS, MOLECULAR; MUTATION; OXYGEN; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SERPINS; THROMBIN;

ANIMALIA;

EID: 8644259055     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.2004.04367.x     Document Type: Article

References (42)

1. Tollefsen, D.M. (1997) Heparin cofactor II. Adv. Exp. Med. Biol. 425, 35-44.
2. Church, F.C., Noyes, C.M. & Griffith, M.J. (1985) Inhibition of chymotrypsin by heparin cofactor II. Proc. Natl Acad. Sci. USA 82, 6431-6434.
3. Parker, K.A. & Tollefsen, D.M. (1985) The protease specificity of heparin cofactor II. J. Biol. Chem. 260, 3501-3505.
4. Silverman, G.A., Bird, P.I., Carrell, R.W., Church, F.C., Coughlin, P.B., Gettins, P.G., Irving, J.A., Lomas, D.A., Luke, C.J., Moyer, R.W., Pemberton, P.A., Remold-O'Donnell, E., Salvesen, G.S., Travis, J. & Whisstock, J.C. (2001) The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276, 33293-33296.
5. Gettins, P.G.W. (2002) Serpin structure, mechanism, and function. Chem. Rev. 102, 4751-4804.
6. Stratikos, E. & Gettins, P.G.W. (1999) Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 Å and full insertion of the reactive center loop into beta-sheet A. Proc. Natl Acad. Sci. USA 96, 4808-4813.
7. Huntington, J.A., Read, R.J. & Carrell, R.W. (2000) Structure of a serpin-proteinase complex shows inhibition by deformation. Nature 407, 923-926.
8. Izaguirre, G., Zhang, W., Swanson, R., Bedsted, T. & Olson, S.T. (2003) Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin. J. Biol. Chem. 278, 51433-51440.
9. Ragg, H., Ulshöfer, T. & Gerewitz, J. (1990) On the activation of human leuserpin-2, a thrombin inhibitor, by glycosaminoglycans. J. Biol. Chem. 265, 5211-5218.
10. Van Deerlin, V.M.D. & Tollefsen, D.M. (1991) The N-terminal acidic domain of heparin cofactor II mediates the inhibition of α-thrombin in the presence of glycosaminoglycans. J. Biol. Chem. 266, 20223-20231.
11. Mitchell, J.W. & Church, F.C. (2002) Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition. J. Biol. Chem. 277, 19823-19830.
12. Baglin, T.P., Carrell, R.W., Church, F.C., Esmon, C.T. & Huntington, J.A. (2002) Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proc. Natl Acad. Sci. USA 99, 11079-11084.
13. Ragg, H. (1986) A new member of the plasma protease inhibitor gene family. Nucleic Acids Res. 14, 1073-1088.
14. Blinder, M.A., Marasa, J.C., Reynolds, C.H., Deaven, L.L. & Tollefsen, D.M. (1988) Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coli. Biochemistry 27, 752-759.
15. Griffith, M.J. (1983) Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin. Proc. Natl Acad. Sci. USA 80, 5460-5464.
16. Verhamme, I.M., Bock, P.E. & Jackson, C.M. (2004) The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II. J. Biol. Chem. 279, 9785-9795.
17. Liaw, P.C., Austin, R.C., Fredenburgh, J.C., Stafford, A.R. & Weitz, J.I. (1999) Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II. J. Biol. Chem. 274, 27597-27604.
18. Myles, T., Church, F.C., Whinna, H.C., Monard, D. & Stone, S.R. (1998) Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes. J. Biol. Chem. 273, 31203-31208.
19. Picard, V., Ersdal-Badju, E., Lu, A. & Bock, S. (1994) A rapid and efficient one-tube PCR-based mutagenesis technique using Pfu DNA polymerase. Nucleic Acids Res. 22, 2587-2591.
20. Ge, L. & Rudolph, P. (1997) Simultaneous introduction of multiple mutations using overlap extension PCR. Biotechniques 22, 28-30.
21. Böhme, C., Nimtz, M., Grabenhorst, E., Conradt, H.S., Strathmann, A. & Ragg, H. (2002) Tyrosine sulfation and N-glycosylation of human heparin cofactor II from plasma and recombinant Chinese hamster ovary cells and their effects on heparin binding. Eur. J. Biochem. 269, 977-988.
22. Schneider, C., Newman, R.A., Sutherland, D.R., Asser, U. & Greaves, M.F. (1982) A one-step purification of membrane proteins using a high efficiency immunomatrix. J. Biol. Chem. 257, 10766-10769.
23. Karlsson, G.B. & Platt, F.M. (1991) Analysis and isolation of human transferrin receptor using the OKT-9 monoclonal antibody covalently crosslinked to magnetic beads. Anal. Biochem. 199, 219-222.
24. Winter, J., Lilie, H. & Rudolph, R. (2002) Renaturation of human proinsulin - a study on refolding and conversion to insulin. Anal. Biochem. 310, 148-155.
25. Zeng, F.Y., Hopp, A., Soldner, A. & Wess, J. (1999) Use of a disulfide cross-linking strategy to study muscarinic receptor structure and mechanisms of activation. J. Biol. Chem. 274, 16629-16640.
26. Kellner, R. (1994) Cyanogen bromide cleavage. In Microcharacterization of Proteins (Kellner, R., Lottspeich, F. & Meyer, H.E., eds), pp. 19-22. VCH-Verlagsgesellschaft, Weinheim, Germany.
27. Knight, C.G. (1995) Active-site titration of peptidases. Methods Enzymol. 248, 85-101.
28. Ciaccia, A.V., Willemze, A.J. & Church, F.C. (1997) Heparin promotes proteolytic inactivation by thrombin of a reactive site mutant (L444R) of recombinant heparin cofactor II. J. Biol. Chem. 272, 888-893.
29. Darby, N. & Creighton, T.E. (1997) Probing protein folding and stability using disulfide bonds. Mol. Biotechnol. 7, 57-77.
30. Tollefsen, D.M., Pestka, C.A. & Monafo, W.J. (1983) Activation of heparin cofactor II by dermatan sulfate. J. Biol. Chem. 258, 6713-6716.
31. Church, F.C., Meade, J.B. & Pratt, C.W. (1987) Structure-function relationships in heparin cofactor II: spectral analysis of aromatic residues and absence of a role for sulfhydryl groups in thrombin inhibition. Arch. Biochem. Biophys. 259, 331-340.
32. Matsumura, M. & Matthews, B.W. (1991) Stabilization of functional proteins by introduction of multiple disulfide bonds. Methods Enzymol. 202, 336-356.
33. 2+-induced conformational transitions in calmodulin with disulfide bonds. J. Biol. Chem. 271, 7479-7483.
34. Tiebel, B., Aung-Hilbrich, L.M., Schnappinger, D. & Hillen, W. (1998) Conformational changes necessary for gene regulation by Tet repressor assayed by reversible disulfide bond formation. EMBO J. 17, 5112-5119.
35. Shimaoka, M., Lu, C., Palframan, R.T., von Andrian, U.H., McCormack, A., Takagi, J. & Springer, T.A. (2001) Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin alphaL I domains with high affinity and antagonist activity in vivo. Proc. Natl Acad. Sci. USA 98, 6009-6014.
36. De Taeye, B., Compernolle, G., Dewilde, M., Biesemans, W. & Declerck, P.J. (2003) Immobilization of the distal hinge in the labile serpin plasminogen activator inhibitor 1: identification of a transition state with distinct conformational and functional properties. J. Biol. Chem. 278, 23899-23905.
37. Wright, P.E. & Dyson, H.J. (1999) Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 293, 321-331.
38. Uversky, V.N. (2002) What does it mean to be natively unfolded? Eur. J. Biochem. 269, 2-12.
39. Hortin, G., Tollefsen, D.M. & Strauss, A.W. (1986) Identification of two sites of sulfation of human heparin cofactor II. J. Biol. Chem. 261, 15827-15830.
40. Ragg, H., Ulshöfer, T. & Gerewitz, J. (1990) Glycosaminoglycan-mediated leuserpin-2/thrombin interaction: structure-function relationships. J. Biol. Chem. 265, 22386-22391.
41. Eckert, R. & Ragg, H. (2003) Zinc ions promote the interaction between heparin and heparin cofactor II. FEBS Lett. 541, 121-125.
42. Hayakawa, Y., Hayashi, T., Lee, J.B., Ozawa, T. & Sakuragawa, N. (2000) Activation of heparin cofactor II by calcium spirulan. J. Biol. Chem. 275, 11379-11382.